Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Establishment Labs Holdings ( (ESTA) ) is now available.
Juan José Chacón-Quirós, CEO of Establishment Labs, announced his retirement effective March 1, 2025, while continuing as a board member and advisor. Peter Caldini, the current President, will serve as Interim CEO. Establishment Labs also shared preliminary unaudited fourth quarter revenue figures which align with recent guidance, showcasing the company’s continued growth and market presence in the breast aesthetics industry.
More about Establishment Labs Holdings
Establishment Labs Holdings Inc. is a global medical technology company focused on improving women’s health and wellness, particularly in breast aesthetics and reconstruction. The company offers a range of solutions in over 90 countries, including the Motiva breast implant line, and is known for its innovations in minimally invasive technologies.
YTD Price Performance: 1.13%
Average Trading Volume: 420,298
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.32B
For a thorough assessment of ESTA stock, go to TipRanks’ Stock Analysis page.